发明名称 |
CANCER MONITORING AND THERAPEUTICS |
摘要 |
Provided for are three novel isoenzyme variants of the human Hyaluronan Synthase gene, HAS 1 V a, HAS 1 Vb, and HAS 1 Vc. Also provided is a method for assessing disease, or susceptibility to disease, in a patient; in which a cell or sample of a cell population is mixed with at least one compound which specifically binds to HAS 1 Va, HAS 1 Vb, HAS 1 Vc or HAS2 isoenzyme or isoenzyme variant genomic mRNA transcript or products arising therefrom; and methods of treatment.
|
申请公布号 |
CA2441681(A1) |
申请公布日期 |
2004.11.22 |
申请号 |
CA20032441681 |
申请日期 |
2003.09.25 |
申请人 |
THE GOVERNORS OF THE UNIVERSITY OF ALBERTA |
发明人 |
ADAMIA, SOPHIA;PILARSKI, LINDA;BELCH, ANDREW;HAY, MARY;REIMAN, TONY |
分类号 |
A61K31/496;A61K31/7088;A61K31/728;A61K38/16;A61K39/395;A61K45/00;A61K48/00;C12N9/10;C12N15/54;C12Q1/02;C12Q1/68;G01N33/53;(IPC1-7):C12N15/54;A61K31/708 |
主分类号 |
A61K31/496 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|